Search for Clinical Trial Results
Filariasis - 48 Studies Found
Status | Study |
Recruiting |
Study Name: Mass Drug Administration for Lymphatic Filariasis and Onchocerciasis for Liberia Condition:
|
Recruiting |
Study Name: Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Ivory Coast (DOLF-Ivory Coast) Condition:
Date: 2007-05-09 |
Completed |
Study Name: Effect of Albendazole Dose on Clearance of Filarial Worms Condition: Lymphatic Filariasis Date: 2006-06-19 Interventions:
|
Active, not recruiting |
Study Name: Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of Africa Condition: Lymphatic Filariasis Date: 2013-10-28 Interventions:
|
Terminated |
Study Name: Efficacy of Higher Albendazole and Ivermectin Doses on Wuchereria Bancrofti Microfilarial Clearance in Malawi Condition: Lymphatic Filariasis Date: 2010-09-30 Interventions:
|
Active, not recruiting |
Study Name: Pharmacokinetics & Pharmacodynamics of Diethylcarbamazine (DEC)+ Albendazole (ALB) + Ivermectin (IVE) Condition: Wuchereria Bancrofti Infection Date: 2016-06-03 Interventions: Drug: Ivermectin, Diethylcarbamazine Albendazole (IDA) To evaluate the safety and tolerability of triple |
Not yet recruiting |
Study Name: Twice Yearly Treatment for the Control of LF Condition:
Date: 2016-11-03 Interventions: Drug: 400 μg/kg Ivermectin + 400 mg Albendazole 400ug/Kg, tablet, given orally once or twice a year |
Not yet recruiting |
Study Name: Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH) Condition:
Date: 2016-12-30 Interventions: Drug: Albendazole Children ages 12-23 months will receive a single dose of 200 mg albendazole and all in |